切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - Free Fatty Acid Receptors - metalloprotease - Insulin and Insulin-like Receptors

10 件产品

每页
清除全部
  1. Phosphoramidon Disodium Salt
    B4790 Phosphoramidon Disodium Salt
    中文名: 磷酰二肽,膦酰二肽钠
    Target: metalloprotease
    Summary: 金属蛋白酶抑制剂
      ≥58.7 mg/mL
      ≥52.5 mg/mL
  2. AH 7614
    B7792 AH 7614
     1 Citation
    Target: Free Fatty Acid Receptors
    Summary: FFA4/GPR120拮抗剂
      ≥35.1 mg/mL
      insoluble in H2O
  3. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  4. GW9508
    A1709 GW9508
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40激动剂
      ≥16.05 mg/mL
      insoluble in H2O
  5. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  6. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  7. TUG-770
    A3895 TUG-770
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40激动剂
      ≥11.85 mg/mL
      insoluble in H2O
  8. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  9. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL
  10. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O

10 件产品

每页